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ABSTRACT 
Objective To assess the contribution of in utero magnetic resonance (iuMR) imaging in 
fetuses diagnosed with ventriculomegaly as the only abnormal intracranial finding on 
antenatal ultrasonography (USS) in the MERIDIAN cohort. 
Methods We report a sub-group analysis from the MERIDIAN study, of cases of fetal 
ventriculomegaly diagnosed on USS who then had iuMR imaging within 2 weeks of USS 
and for whom outcome reference data were available. The diagnostic accuracy of USS 
and iuMR are reported in relation to the severity of ventriculomegaly. We also study the 
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difference in measurements of trigone size on the two imaging methods and present the 
clinical impact of adding iuMR to the diagnostic pathway. 
Results USS failed to detect 31 additional brain abnormalities other than 
‘ventriculomegaly’ in the subgroup of 306 fetuses, giving an overall diagnostic 
accuracy of 89.9% for USS, whilst iuMR correctly detected 27 giving a diagnostic 
accuracy of 98.4% (statistically significant p<0.0001). There were other brain 
abnormalities in 14/244 of fetuses with mild ventriculomegaly on USS (diagnostic 
accuracy 94.3%), and iuMR correctly diagnosed 12 of those (diagnostic accuracy 
98.8%). All of those results reached statistical significance in favour of iuMR. There 
was a close agreement between the size of trigones measured on USS and on iuMR, 
with categorical differences in only 16% of cases. iuMR did not systematically over-
estimate trigone size, as suspected before the study commenced. Complete prognosis 
data were available in 295/306 fetuses and the prognosis category changed after iuMR 
in 69/295 (23.4%) cases. The overall effect of iuMR on clinical management was 
considered to be either ‘significant’, ‘major’ or ‘decisive’ in 76/295 (25.8%) cases. 
Conclusion Our data suggest that any woman whose fetus has ventriculomegaly as the 
only intracranial finding on USS should be offered an adjuvant investigation of iuMR 
for further evaluation. 
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INTRODUCTION 
Women in the UK are offered ‘mid-trimester anomaly scanning’ using ultrasonography 
(USS) at approximately 20 weeks gestational age with the aims set out by the national 
fetal anomaly screening program. These include the identification of serious 
abnormalities incompatible with life or associated with morbidity. Some abnormalities, 
however, are recognised for the first time later in pregnancy when further USS might be 
performed for reasons such as monitoring fetal growth or investigating reduced fetal 
movements. Fetal brain abnormalities are amongst the commonest lesions recognised on 
antenatal USS and are important because of the high risk of detrimental long-term 
neurodevelopmental outcomes. Enlargement of the lateral cerebral ventricles (or 
ventriculomegaly - VM) is by far the commonest intracranial abnormality recognised on 
antenatal USS (approximately 2.5/1000 pregnancies1) but the clinical significance of 
this finding is complex.  VM can be associated with other structural abnormalities (in 
which case the prognosis is often poor) but most often it is the only abnormal 
intracranial finding. In this situation, prognosis is related to the degree of VM, fetuses 
with larger ventricles generally have a higher risk of poor neurodevelopmental outcome.  
The ‘Magnetic Resonance imaging to enhance the diagnosis of fetal developmental 
brain abnormalities in utero’ (MERIDIAN) study2 is a multicentre prospective cohort 
study based in the UK designed to evaluate the diagnostic and clinical benefits of in 
utero Magnetic Resonance (iuMR) imaging in diagnosing fetal brain pathology 
antenatally. A description of the overall findings from the cohort has been reported 
previously3 and has confirmed major diagnostic and management impact when iuMR is 
included in the diagnostic pathway. At the planning stage of the study, focus groups of 
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fetal medicine consultants were asked what information MERIDIAN should attempt to 
provide in order to improve clinical practice and the most frequent response called for a 
sub-group analysis of apparently isolated VM on USS. In this paper, we detail the 
diagnostic and clinical impact brought about by including iuMR in the diagnostic 
pathway in 306 fetuses with VM as the only abnormality shown on antenatal USS. 
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METHODS 
The fetuses reported in this paper came from the MERIDIAN cohort and the 
overarching methodology of that study is reported elsewhere2,3 but the parts relevant to 
this paper are summarised here. MERIDIAN was undertaken in accordance with the 
Medicines for Human Use (Clinical Trials) Regulations 2004 and ethics approval was 
obtained for a multi-centre study through the Integrated Research Application System 
(62734).   Inclusion criteria were – pregnant women aged ≥16 years whose fetus had a 
brain abnormality detected by USS at a gestational age of 18 weeks or more, with no 
contraindications to iuMR and gave written, fully informed consent to enter the study. 
Recruitment was from 16 fetal medicine units in the UK.  
Ultrasonography and iuMR imaging 
All of the USS studies were performed by appropriately trained NHS consultants in 
fetal medicine and they recorded each brain abnormality using nomenclature from the 
“ViewPoint” antenatal ultrasound reporting software (GE Healthcare, Chalfont St Giles 
UK). Each woman then had an iuMR examination performed on a 1·5T 
superconducting clinical MR system at one of six centres. The base requirement for the 
iuMR study was T2-weighted images of the fetal brain in the three orthogonal planes 
and a T1-weighted ultrafast sequence in at least one plane (usually axial).  The reporting 
radiologist was aware of the diagnoses made on USS from the study paperwork and also 
had access to the full clinical USS report. The radiologist was required to comment on 
each brain abnormality recognised on USS (using ‘diagnosis excluded’ if the finding 
was not present on iuMR) and added extra anatomical diagnoses where appropriate onto 
a similar form as used for USS.  
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In cases where the pregnancy continued and the child survived, outcome reference data 
(ORD) was obtained from the clinical notes based on diagnoses made on postnatal 
neuroimaging studies up to the age of six months, with the exception of those fetuses 
described in b) below. In cases of Termination of pregnancy (TOP), stillbirth or 
neonatal deaths the ORD was based on autopsy and/or post-mortem MR imaging. An 
independent paediatric neuroradiologist determined whether a full review by a 
Multidisciplinary Independent Expert Panel (MIEP) was required. Review was required 
in every case unless;  
a) There was complete and unequivocal agreement between the abnormal 
findings on USS, iuMR and the ORD; or 
b) VM was the only finding described on both USS and iuMR examinations but 
the size of the ventricles had returned to normal as shown on USS later in 
pregnancy or on neonatal imaging. The latter was counted as agreement in 
recognition that VM commonly resolves spontaneously during later pregnancy. 
The MIEP consisted of three consultants working in the NHS (neuroradiologist, fetal 
medicine consultant, and paediatric neurologist) from a centre that did not recruit into 
MERIDIAN. They were asked to judge if the USS-based diagnoses and iuMR-based 
diagnoses were in complete agreement with the ORD. The primary analysis in 
MERIDIAN centred on participants who underwent iuMR within 14 days of USS and 
for whom ORD was available and consisted of a calculation of diagnostic accuracy for 
USS and iuMR studies  defined as;  
[True positives + True negatives]/Total number of cases  
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Potential differences in the diagnostic accuracies of USS and iuMR were assessed by 
McNemar’s paired binomial test. The subgroup reported in this paper consists of 
women who were recruited into MERIDIAN carrying a fetus with VM as the only 
finding on USS. Fetal VM was categorised into three groups based on the size of the 
largest trigone measured on USS as used clinically in the referring centres namely;  
• mild (10, 11 and 12mm)  
• moderate (13, 14 and 15mm)  
• severe (16mm and over).  
Presence of other brain abnormalities 
The main analysis consists of calculations of diagnostic accuracy of USS and iuMR by 
comparing of the ORD with the imaging-based diagnoses in the entire sub-group and 
then in relation to the severity of VM diagnosed on USS.   
Assessment of ventricular size 
The fetal medicine consultant performing the USS was asked to record the ventricular 
measurements as left or right trigone and to specify which one was the near-field 
measurement. There are frequently problems in visualising the near-field ventricle on 
USS and hence measurements may be difficult for that hemisphere. The trigone 
measurements made on iuMR imaging were recorded and compared with the USS-
derived measurements. We first compared the category of VM made on USS and iuMR 
by taking the size of the largest trigone and classified it as mild, moderate or severe 
using the definitions given above. We then compared the absolute measurements of the 
left and right trigones made on USS and iuMR and describe the difference in order to 
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judge the degree of agreement. We also compared the degree of agreement in relation to 
which measurement was near-field and which was far-field on USS. 
We also assessed the risk of other brain abnormalities in relation to unilateral or 
asymmetric VM as judged by iuMR imaging. In accordance with our previous 
publications, unilateral VM is defined in a fetus with one trigone measurement of 
≥10mm and the other within the normal range. Asymmetric VM is defined in a fetus 
where both trigone measurements are  ≥10mm but there is a difference between the two 
sides of ≥3mm. Fisher’s Exact test was used to test for a statistically significant 
difference in other brain abnormalities between unilateral and asymmetric VM.  
Effects on clinical management 
MERIDIAN captured data from the fetal medicine specialists about changes in 
prognosis and clinical management brought about by iuMR as described in detail 
elsewhere3 and we have included that data in the assessment of value of iuMR data. The 
fetal medicine specialist was asked to record the predicted prognosis on each case 
before the iuMR study was performed i.e. based on USS information only. Five 
categories were used:   
1) Normal - no worse than the risk to a fetus without a demonstrable brain abnormality  
2) Favourable - Normal neurological outcome expected in >90% of cases  
3) Intermediate - Normal neurological outcome expected in 50 to 90% of cases  
4) Poor - Normal neurological outcome expected in <50% of cases  
5) Unknown  
At the next consultation with the woman, at which time the iuMR report was available, 
the clinician was asked if iuMR had provided any extra diagnostic information. They 
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also recorded the updated prognostic information using the same five categories. For the 
purposes of description in this report we describe if the prognosis remained the same 
worsened or improved after iuMR. This approach is straightforward when prognoses 
were in groups 1) to 4) or if the prognosis was ‘Unknown’ on both USS and iuMR. 
Problems arise when the prognosis on one imaging method was ‘Unknown’ but 
specified on the other. We elected to assign: 
• USS prognosis ‘Unknown’, iuMR prognosis ‘Normal’ or ‘Favourable’ = 
improved prognosis 
• USS prognosis ‘Unknown’, iuMR prognosis ‘Intermediate’ = no change in 
prognosis 
• USS prognosis ‘Unknown’, iuMR prognosis ‘Poor’ = worse prognosis 
• USS prognosis  ‘Normal’ or ‘Favourable’, MR prognosis ‘Unknown’ = worse 
prognosis 
• USS prognosis  ‘Intermediate’, MR prognosis ‘Unknown’ = no change in 
prognosis 
• USS prognosis  ‘Poor’, MR prognosis ‘Unknown’ = no change in prognosis 
 
Clinicians were asked if TOP was offered because the abnormalities on USS only were 
sufficient to consider that option under Ground E of the Abortion Act (section 1(1)(d) – 
substantial risk of serious mental or physical handicap).4 They were subsequently asked 
if they would now offer TOP with the combined results. Finally, the fetal medicine 
specialists were asked to rate the overall contribution iuMR to the final clinical 
management choice using a five point descriptive scale; a) No effect, b) Minor effect, c) 
Significant effect, d) Major effect, and e) Decisive effect.  
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RESULTS 
The primary MERIDIAN cohort consisted of 570 fetuses with ORD and in whom the 
iuMR study was done within 2 weeks of the referring USS study. 421 (73.9%) of those 
fetuses had VM as part of the USS diagnosis and in 306/570 (53.7%) VM was the only 
intracranial abnormality shown on USS.  Those 306 cases form the basis of this report 
and the gestational age at which iuMR was performed in that group is shown in figure 1. 
199/306 fetuses (65%) had their iuMR studies between 18 and 23 weeks and 107/306 
(35%) at or after 24 weeks. 244/306 (80%) fetuses had mild VM, 36/306 (12%) 
moderate VM and 26/306 (8%) severe VM according to the largest of the trigone 
measurements on USS.  14/306 (5%) had known non-brain abnormalities, including 5 
cardiac abnormalities, 3 thoracic, 3 head and neck, 2 abdominal and 1 genitourinary. 
11/306 (4%) had chromosomal or genetic abnormalities, shown in table 1.  
Presence of other brain abnormalities 
Additional brain abnormalities other than VM were found on ORD in 31/306 fetuses 
(10.1%), 17/199 (8.5%) in the 18-23 week group and 14/107 (13.1%) in the ≥24 week 
group. Other brain abnormalities were shown in 5.7% (14/244) of fetuses with mild 
VM, 19.4% (7/36) of fetuses with moderate VM rising to 38.5% (10/26) of fetuses with 
severe VM (table 2). Those brain abnormalities consisted of:  
• Failed commissuration (agenesis and hypogenesis of the corpus callosum) in 
17/31 (55%). Three cases had other significant brain/eye abnormalities 
• Encephalomalacia and/or intracranial haemorrhage in 8/31 (26%) 
• Cortical formation abnormalities in 4/31 (13%) 
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• Absent cavum septum pellucidum due to septo-optic dysplasia in 2/31 (6%)  
 ‘Acquired brain pathologies’ (i.e. encephalomalacia or intracranial haemorrhage 
accounted for 1/17 (7%) cases of brain abnormalities in the 18 to 23 week group and 
7/14 (50%) cases in the ≥24 weeks group. ‘Acquired brain pathologies’ were most 
frequently found in conjunction with moderate or severe VM. When the results of iuMR 
studies were compared with the ORD results there was complete agreement in 302/306 
fetuses, of which 27 cases had additional pathologies and 275 cases were confirmed to 
have VM alone. The four fetuses incorrectly diagnosed on iuMR consisted of three 
cases of failed commissuration (all hypogenesis of the corpus callosum) and one case of 
absent cavum septum pellucidum. Representative cases are shown in figures 2-6. 
Assessment of ventricular size 
VM was the only intracranial finding on USS, iuMR and ORD in 275 fetuses - mild VM 
in 230/275 (84%), moderate VM in 29/275 (10%) and severe VM in 16/275 (6%) based 
on USS measurements.  The trigone measurements of the 275 iuMR studies were 
compared with the equivalent USS measurements, and agreement by category (i.e. mild, 
moderate or severe) was found in 230/275 (84%) and disagreement by category in 
45/275 (16%). In all but one case the degree of disagreement was only one category 
(table 3), including 4 cases in which the iuMR measurements of the trigones were 
within the normal range.  
In 42/275 cases (15%) only one trigone could be measured on USS because of near-
field effects, so it was only possible to compare the absolute measurements of 508 
trigones on USS and iuMR (both trigones in 233 cases and one trigone in 42 cases – 
figure 7). In 142/508 (28%) the trigone measurements made on USS and iuMR agreed 
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to the nearest millimetre, 326/508 (64%) measurements were within ±1mm and 409/508 
(81%) were within ±2mm. The distribution of the differences was symmetrical, 
indicating that there is no tendency for iuMR to systematically either under-estimate or 
over-estimate the trigone size compared with USS. 
It was possible to make a direct comparison of trigone measurements made on USS and 
iuMR with the knowledge of which USS measurement was near-field and which was 
the far-field in 197 fetuses with 394 trigones. In 36 cases the near-field/far-field 
information was not recorded and in 42 cases it was only possible to measure the far-
field trigone on USS. In the 197 cases that could be assessed there was no significant 
difference in the level of agreement between the measurements made on near-field and 
the far-field measurements trigones - difference (modulus) for near field measurements 
(1.6 ± 1.8mm) and for far field (1.5 ± 1.9mm) indicating close correlation in those 
ventricles that could be visualised on USS. 
109/306 (35.6%) fetuses had unilateral VM and 44/306 (14.4%) fetuses had asymmetric 
VM on iuMR imaging. Other brain abnormalities were found in 2/109 (1.8%) fetuses 
with unilateral VM (both with cortical formation abnormalities) and 5/44 (11.4%) 
fetuses with asymmetric VM (four cases of failed commissuration [with a cortical 
formation abnormality in one] and one case of intracranial haemorrhage) with a 
statistically significant difference of 9.6% (p=0.0213). This is compared with a rate of 
brain abnormalities of 23/149 (15.4%) in fetuses with symmetric VM. NB there were 4 
fetuses in which VM was excluded on iuMR imaging.  
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Effects on clinical management  
There was incomplete prognosis/management data in 11/306 (3%) cases hence it was 
possible to study effects on prognosis/management brought about by the iuMR in 295 
fetuses; this included 29/31 fetuses with other brain abnormalities (table 4). In 106/295 
(35.9%) cases fetal medicine consultants recorded that iuMR provided additional 
information over that available on USS. The prognosis category changed after iuMR in 
69/295 (23.4%) cases, in 22 cases the prognosis was worse after iuMR and in 47 the 
prognosis was improved after iuMR. TOP was offered to 42/295 (14.2%) women on the 
basis of the USS alone and in eight of those cases the offer of TOP was reversed on the 
basis of iuMR imaging. In addition, TOP was offered to a further 14 women after iuMR 
on the basis of brain abnormalities other than VM being diagnosed (see below and table 
4). As a consequence, the decision to offer TOP was changed after iuMR in 22/295 
(7.5%) fetuses. Termination was performed in 14/295 (4.7%) cases. The effect of iuMR 
on clinical management on the whole group of 295 fetuses according to the fetal 
maternal expert was described as none (14%), minor (61%), significant (21%), major 
(4%) and decisive (0.3%) 
A detailed summary of the effects on prognosis and management on the 29/295 fetuses 
that had brain pathology other than VM and complete prognosis/management data is 
presented in table 4. Prognosis was considered worse after iuMR in 13/29 (44.8%) cases 
and the effect of iuMR on overall clinical management was ‘significant’, ‘major’ or 
‘decisive’ in 15/29 (51.7%). 
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DISCUSSION 
VM refers to enlargement of the ventricular system and can involve some, or all, of the 
cerebral ventricles but the clinical assessment of ventricular size on antenatal USS is 
centred on the trigones of the lateral ventricles. To reduce the subjective nature of 
assessing ‘enlarged ventricles’, ultrasonographers have devised a reproducible method 
for assessing the trigone size of the lateral ventricles5.  A measurement of ≥10mm is 
considered to be abnormal at any stage of pregnancy as this is approximately 4 standard 
deviations above the mean. This definition is generally accepted for fetal VM in the UK 
and used in MERIDIAN. It should be appreciated that it is possible to have VM 
involving other parts of the ventricular system (e.g. frontal horns) with trigone 
measurements <10mm, these cases are relatively rare and have not been included 
herein. 
VM can be categorised further based on the largest trigone size.  The MERIDIAN 
recruiting centres use three categories, mild (10-12mm), moderate (13-15mm) and 
severe (≥16mm). The extra level of detail allows correlation with long-term neuro-
developmental outcomes in cases where VM is the only abnormality. All referring 
centres in MERIDIAN regard ‘isolated’ mild VM as low risk and place such fetuses in 
the ‘Favourable - Normal neurological outcome expected in ≥90% of cases’ group. 
Specifically, half quote ≥90% chance of normal outcomes and the other half quote 
≥95%. There was considerable variation in the prognosis given to fetuses with 
moderate VM. Of the 36 cases of moderate VM on USS, full prognosis/management 
data was available in 34. The referring fetal medicine consultants gave a ‘favourable’ 
prognosis to 7/34, ‘intermediate’ prognosis to 21/34, ‘poor’ prognosis to 5/34 and 1/34 
‘not known’ before iuMR imaging. This is in spite of robust information in published 
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literature that mostly describes ‘intermediate’ prognosis. Similarly, there is robust 
published literature about the ‘poor’ prognosis for fetuses with severe6 but the 24 
fetuses with severe VM in this study with full prognosis/management data were given 
an ‘Intermediate’ prognosis in 8/24 and ‘Poor’ in 16/24 after USS alone. This indicates 
a degree of clinical uncertainty in the UK.  Future follow-up studies of the MERIDIAN 
cohort may provide results in order to clarify this uncertainty. 
 
The overall rates of unilateral and asymmetric VM are in line with our previous 
publications7,8. In this study we have shown that the risk of another brain abnormality is 
reduced in fetuses with unilateral VM when compared to those with bilateral VM (9.6% 
difference, p=0.0213). This is in comparison with asymmetric VM cases, in whom the 
risk is no different from the bilateral group. 
 
There is now considerable evidence supporting the value of iuMR in diagnosing fetal 
brain abnormalities, based on systematic reviews9-12 and our prospective study3. Whilst 
designing MERIDIAN we formed fetal medicine focus groups to identify important 
issues to be addressed. One major recommendation was the need to perform separate 
analyses on anatomical sub-groups of fetal brain abnormalities, including isolated VM. 
Some questions related to differences in the technical measurements of the ventricles on 
USS and iuMR, specifically there was an impression that iuMR over-estimated ventricle 
size compared with USS. The depth of problems arising from near-field effects on USS 
was also identified for investigation. We have attempted to address those issues herein 
but the leading issue raised by the focus groups was the widely held belief that when 
mild VM is the only intracranial finding on USS the diagnosis is invariably correct and 
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does not require iuMR imaging. This is of importance to healthcare funders because, if 
that opinion is correct, the resources required to provide a clinical service are 
significantly reduced.  
The sub-group analysis of VM cases from MERIDIAN presented here shows additional 
brain abnormalities were present in 31/306 (10.1%) of fetuses overall and there was a 
higher rate of brain abnormalities in the more severe VM categories, which is 
comparable with our previous report, although ORD was not available in that study7,8. 
Other brain abnormalities were shown in 5.7% (14/244) of fetuses with mild VM, 
19.4% (7/36) of fetuses with moderate VM rising to 38.5% (10/26) of fetuses with 
severe VM, compared with 6%, 14% and 57% respectively in our previous work. iuMR 
demonstrated 27/31 of the other brain abnormalities and improved diagnostic accuracy 
in all VM categories.  A factor that has the potential to reduce the diagnostic accuracy 
of USS is the deleterious results of the near-field effect. Although there is good 
correlation of trigone sizes between USS and iuMR when trigones can be visualised on 
USS, we have shown that in 15% of the cases reported one cerebral hemisphere was not 
visualised to a degree that the trigone of the lateral ventricle could not be measured. 
This is likely to be an important diagnostic limitation generally but particularly in cases 
of unilateral pathology if it involves the ‘near-field’ hemisphere. This can interfere with 
the detection of both developmental brain pathology (cortical formation abnormalities 
are frequently unilateral) and acquired pathology (e.g. haemorrhage and 
encephalomalcia). 
iuMR had a major clinical impact in cases of USS-diagnosed VM. The prognosis was 
changed in 23.4% and the overall effect on clinical management was considered to be 
‘Significant’, ‘Major’ or ‘Decisive in over 25% of cases. The decision to discuss TOP 
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was changed in 7.5% of foetuses, this included reversing a decision to offer TOP based 
on USS (8 fetuses) and offering TOP after iuMR that was made after USS alone (14 
fetuses). 
In conclusion, based on our current data we believe that iuMR imaging should be 
offered to all women in whom a diagnosis of VM as the sole intracranial abnormality is 
made on USS. As a minimum, women should be advised that even in cases of mild VM 
there is a 1 in 20 chance that additional brain abnormalities have been overlooked on 
USS and this increases with higher categories of VM. The absolute measurements of the 
size of the trigones of the lateral ventricles are very similar on USS and iuMR, in 
particular iuMR does not appear to systematically over-estimate the size. 
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FIGURE LEGENDS 
Figure 1. Gestational ages of 306 fetuses with ‘ventriculomegaly only’ on ante-natal 
USS at the time of iuMR imaging. 
Figure 2. Severe VM was detected in this fetus on USS but no other intracranial 
abnormalities were shown. Severe VM was confirmed on iuMR (axial images 2a and 
2b) along with features consistent with communicating hydrocephalus; enlargement of 
all cerebral ventricles, large head, reduced extra-axial CSF spaces. Intraventricular clot 
is shown (mainly in the trigone and occipital horns of the left lateral ventricle) on the 
axial images (2a and 2b), coronal (2c) and sagittal (2d) images. All of those features 
were confirmed on post-natal imaging (not shown). 
Figure 3. A fetus with severe VM diagnosed on USS and iuMR performed at 36 weeks 
gestational age. VM was confirmed on axial (3a) coronal (3b) and images and is 
markedly asymmetric, right worse than left. There is also marked loss of white matter 
volume adjacent to right lateral ventricle and there is abnormal high signal in the 
adjacent periventricular/deep white matter diagnosed as encephalomalacia. Those 
features were confirmed on post-natal MR imaging (3c and 3d). 
Figure 4.  A fetus with severe VM diagnosed on USS. iuMR was performed at 28 weeks 
gestation which showed colpocephaly on axial iuMR images (4a) along with agenesis of 
the corpus callosum on sagittal (4b) and coronal (4c and 4d) images. Those features 
were confirmed on post-natal imaging (not shown). 
Figure 5. A fetus with mild VM on USS. iuMR was performed at 22 weeks gestation 
and showed colpocepahly on the axial iuMR image (5a) and agenesis of the corpus 
callosum on the coronal (5b) images. In addition, there is marked irregularity of and 
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reduced volume of the right frontal lobe (5c-5d) consistent with a cortical formation 
abnormality, probably polymicrogyria, which was confirmed on autopsy. 
Figure 6.  A fetus with mild VM diagnosed on USS. iuMR was performed at 21 weeks 
gestation, which confirmed mild VM/colpocephaly on the axial image (6a) but also 
showed agenesis of the corpus callosum (6a and 6b).  Axial image at the level of the 
cerebellum (6c) and coronal image through the face (6d) shows poor development of the 
right globe leading to a diagnosis of Aicardi syndrome. All of those features were 
confirmed on autopsy.  
Figure 7. Differences in 506 trigone measurements made on ultrasonography and iuMR 
imaging in fetuses with ‘ventriculomegaly only’ on ante-natal ultrasonography, in utero 
MR imaging and confirmed on the outcome reference data. 
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Table 1. 
Chromosomal / genetic abnormality Number of fetuses 
Trisomy 21 7 
Aicardi syndrome 1 
Congenital myotonic dystrophy, 
pneumothorax 
1 
Karyotype 47XYY 1 
Trisomy 7q 1 
 
Table 1. The tabulated results of the 11 known chromosomal or genetic abnormalities 
within 306 fetuses.   
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Table 2.  
 
Table 2. The results of cases of ‘ventriculomegaly only’ diagnosed by ultrasonography compared with outcome reference data and the results of 
in utero MR imaging in the same cases compared with outcome reference data. The group ‘all cases of VM only’ includes any severity of VM 
defined as at least one trigone ≥10mm whereas the three other groups have the cases divided by severity of VM (mild = 10-12mm, moderate = 
13-15mm and severe ≥16mm). † Outcome Reference Diagnosis. * McNemar’s test between ultrasonography and in utero MR imaging correct 
diagnoses.  
 
 USS Diagnoses iuMR Diagnoses Comparison of diagnostic accuracy 
Subgroup n 
Other brain 
abnormalities on 
ORD† (n) 
Diagnostic 
accuracy 
Other brain 
abnormalities on ORD† 
correctly diagnosed on 
MR  (n)  
Diagnostic 
accuracy Difference (95% CI) p-value* 
All cases of 
VM only 
306 31 89⋅9% 27 98⋅4% 8⋅5(4⋅9, 12⋅1%) <0⋅0001 
 
Mild  
 
244 
 
14 
 
94⋅3% 
 
12 
 
98·8% 
 
4⋅5(1⋅3, 7·8%) 
 
0⋅0034 
Moderate  36 7 80⋅6% 7 100% 19⋅4(3·7, 35·2%) 0⋅0156 
Severe 26 10 61⋅5% 8 92⋅3% 30⋅8(9⋅2, 52⋅4%) 0⋅008 
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Table 3. 
   Ventricle size based 
on USS 
 
  Mild VM Moderate VM Severe VM 
 Normal 
size 
4 - - 
Ventricle size 
based on iuMR 
Mild 
VM (10-
11.9mm) 
201 9 - 
 Moderate 
VM 
24 16 3 
 Severe 
VM 
1 4 13 
 
Table 3. Differences in the category of ventriculomegaly described on ultrasonography and in utero MR imaging in 275 fetuses with VM as the 
only intracranial finding suspected on USS and iuMR and confirmed on outcome reference data. 
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Table 4 
Case GA at  
iuMR 
USS findings iuMR findings ORD Prognosis 
from USS 
Prognosis 
from iuMR 
TOP offer 
on USS 
TOP offer 
on iuMR 
TOP 
performed 
Effect on 
management 
40 21w Moderate VM Moderate VM 
Absent CSP 
VM 
Absent CSP 
Favourable Favourable No Yes No Minor 
48 34w Mild VM Mild VM VM 
Absent CSP 
Favourable Favourable No No No Minor 
79 22w Mild VM Mild unilateral VM 
CFA 
VM 
CFA 
Favourable Not known No Yes Yes Major 
155 23w Severe VM Severe VM VM 
Hypogenesis CC 
Poor Poor Yes Yes No Significant 
201 31w Moderate VM Severe VM 
ICH
VM 
ICH
Poor Poor Yes Yes No Minor 
209 22w Moderate VM Moderate VM 
Hypoplasia CC and 
cerebellum 
VM 
Hypogenesis CC 
and cerebellum 
Intermediate Not known Yes Yes Yes None 
219 22w Moderate VM Moderate asymmetric 
VM, Agenesis CC 
VM 
Agenesis CC 
Intermediate Intermediate No Yes No Major 
264 37w Severe VM Severe asymmetric 
VM, Agenesis CC 
VM 
Agenesis CC 
Intermediate Poor No Yes No Minor 
297 
Fig 2 
32w Severe VM Severe asymmetric 
VM, ICH 
VM 
ICH 
Poor Poor No Yes No Major 
327 35w Severe VM Severe VM 
Agenesis CC 
VM 
Agenesis CC 
Intermediate Poor No Yes No Major 
340 35w Severe VM Severe asymmetric 
VM, Agenesis CC 
CFA 
VM 
Agenesis CC 
CFA 
Intermediate Poor No Yes Yes Major 
343 28w Mild VM Mild VM 
encephalomalacia 
VM 
encephalomalacia 
Not known Poor No Yes Yes Major 
433 
Fig 3 
36w Severe VM Severe VM 
encephalomalacia 
VM 
encephalomalacia 
Intermediate Intermediate No No No Significant 
482 23w Severe VM Severe asymmetric 
VM 
VM 
Hypogenesis CC 
Poor Poor Yes Yes No Minor 
489 22w Mild VM Mild VM VM 
Hypogenesis CC 
Favourable Favourable No No No Minor 
495 28w Mild VM Mild VM 
ICH 
VM 
ICH 
Favourable Favourable No No No Minor 
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509 24w Moderate VM Severe VM 
ICH 
VM 
ICH 
Poor Poor No Yes Yes Significant 
528 22w Mild VM Mild VM 
Agenesis CC 
VM 
Agenesis CC 
Favourable Intermediate No No No Minor 
543 36w Severe VM Severe VM 
Agenesis CC 
VM 
Agenesis CC 
Poor Poor Yes Yes No None 
590 
Fig 6 
21w Mild VM Mild VM 
Agenesis CC 
Microphthalmia 
Aicardi syndrome 
VM 
Agenesis CC 
Microphthalmia 
Aicardi syndrome 
Favourable Poor No Yes Yes Major 
704 22w Mild VM Mild VM 
CFA
VM 
CFA
Favourable Not known No Yes Yes Significant 
732 23w Mild VM Mild VM 
CFA 
VM 
CFA 
Favourable Intermediate No No No Minor 
735 21w Mid VM Mild unilateral VM 
CFA 
VM 
CFA 
Intermediate Poor No Yes No Major 
753 22w Mild VM Mild VM 
ICH 
VM 
ICH 
Intermediate Intermediate No No No Minor 
761 
Fig 5 
22w Mild VM Mild VM 
Agenesis CC 
CFA 
VM 
Agenesis CC 
CFA 
Favourable Poor No Yes Yes Decisive 
767 
Fig 4 
28w Severe VM Severe VM 
Agenesis CC
Severe VM 
Agenesis CC
Poor Poor Yes Yes No Minor 
943 34w Mild VM Mild VM 
Hypogenesis CC 
CFA 
VM 
Hypogenesis CC 
CFA 
Favourable Poor No Yes No Major 
1041 19w Mild VM Mild VM 
Hypogenesis CC 
VM 
Hypogenesis CC 
Favourable Not known No No No Significant 
1053 21w Moderate VM Mild VM 
Hypogenesis CC 
VM 
Hypogenesis CC 
Intermediate Poor No No No None 
 
Table 4. Imaging information for the 29 cases in which a diagnosis of ‘ventriculomegaly only’ was made on ante-natal USS but other brain 
abnormalities were shown on the outcome reference diagnosis and there was complete prognostic/clinical management data available. See 
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‘Results’ for details.  CSP = cavum septum pellucidum, CFA = Cortical formation abnormality, Hypogenesis CC = hypogenesis of the corpus 
callosum, Agenesis CC = agenesis of the corpus callosum, ICH = Intracranial haemorrhage. 
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Gestational ages of 306 fetuses with ‘ventriculomegaly only’ on ante-natal USS at the time of iuMR imaging. 
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For Peer Review
  
 
 
Severe VM was detected in this fetus on USS but no other intracranial abnormalities were shown. Severe VM 
was confirmed on iuMR (axial images 2a and 2b) along with features consistent with communicating 
hydrocephalus; enlargement of all cerebral ventricles, large head, reduced extra-axial CSF spaces. 
Intraventricular clot is shown (mainly in the trigone and occipital horns of the left lateral ventricle) on the 
axial images (2a and 2b), coronal (2c) and sagittal (2d) images. All of those features were confirmed on 
post-natal imaging (not shown).  
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A fetus with severe VM diagnosed on USS and iuMR performed at 36 eeks gestational age. VM was 
confirmed on axial (3a) coronal (3b) and images and is markedly asymmetric, right worse than left. There is 
also marked loss of white matter volume adjacent to right lateral ventricle and there is abnormal high signal 
in the adjacent periventricular/deep white matter diagnosed as encephalomalacia. Those features were 
confirmed on post-natal MR imaging (3c and 3d).  
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
For Peer Review
  
 
 
A fetus with severe VM diagnosed on USS. iuMR was performed at 28 weeks gestation which showed 
colpocephaly on axial iuMR images (4a) along with agenesis of the corpus callosum on sagittal (4b) and 
coronal (4c and 4d) images. Those features were confirmed on post-natal imaging (not shown).  
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A fetus with mild VM on USS. iuMR was performed at 22 weeks gestation and showed colpocepahly on the 
axial iuMR image (5a) and agenesis of the corpus callosum on the coronal (5b) images. In addition, there is 
marked irregularity of and reduced volume of the right frontal lobe (5c-5d) consistent with a cortical 
formation abnormality, probably polymicrogyria, which was confirmed on autopsy.  
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A fetus with mild VM diagnosed on USS. iuMR was performed at 21 weeks gestation, which confirmed mild 
VM/colpocephaly on the axial image (6a) but also showed agenesis of the corpus callosum (6a and 
6b).  Axial image at the level of the cerebellum (6c) and coronal image through the face (6d) shows poor 
development of the right globe leading to a diagnosis of Aicardi syndrome. All of those features were 
confirmed on autopsy.  
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Differences in 506 trigone measurements made on ultrasonography and iuMR imaging in fetuses with 
‘ventriculomegaly only’ on ante-natal ultrasonography, in utero MR imaging and confirmed on the outcome 
reference data.  
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